Gilead

US buys entire global stock of remdesivir for next 3 months

The US Department of Health and Human Services announced that it will be buying up virtually the entire produced stock of remdesivir from manufacturer Gilead till September. The agency said it secured more than 500,000 remdesivir courses for US hospitals through September. That represents all of Gilead’s projected production for July and 90 per cent...

India approves emergency use of antiviral drug ‘remdesivir’ for COVID-19

The Union government on Tuesday said it has approved Gilead Sciences Inc’s antiviral drug remdesivir for emergency use in treating COVID-19 patients. Remdesivir is the first drug to show improvement in COVID-19 patients in formal clinical trials. It was granted emergency use authorisation by the US Food and Drug Administration last month and has received...

Indian company signs agreement for selling US firm’s COVID-19 drug in 127 countries

India’s Jubilant Life Sciences Ltd has signed a non-exclusive licensing agreement for selling Gilead Sciences Inc’s experimental COVID-19 treatment remdesivir in 127 countries, including India. The drug earlier this month received the US Food and Drug Administration’s emergency use authorisation to treat COVID-19 patients. Jubilant also gets the rights to...